Steven Visuri

Steven Visuri has a diverse work experience, starting with their role as CEO at Stem Pharm, Inc since December 2017. Stem Pharm is a drug discovery company focused on neural organoid platforms for CNS disease modeling and drug screening. Additionally, they co-founded and served as CEO at FloraSeq LLC, a start-up medical therapeutic company specializing in leveraging the gut microbiome for gastrointestinal disorder treatment. Steven also held senior positions at Hologic and Prodesse, Inc, where they were responsible for the development and commercialization of molecular in vitro diagnostic assays for infectious diseases. Prior to that, they worked as a Research Scientist and Group Leader at Lawrence Livermore National Laboratory, specializing in the development of medical devices and obtaining significant funding and patents in this field. Steven has also been an active member and Chair of the Healthcare Committee at Golden Angels Network since October 2013 and co-founded Reflourish, LLC in 2018. Overall, Steven Visuri has demonstrated expertise in various areas of healthcare and medical technology.

Steven Visuri completed their Bachelor of Science degree in Electrical Engineering from Marquette University in the years 1984 to 1989. Steven then pursued further education and obtained their Ph.D. in Biomedical Engineering from Northwestern University between 1989 and 1996.